Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's session, 107 stocks hit new 52-week lows.
Benzinga’s Top Ratings Upgrades, Downgrades For November 29, 2022
Upgrades According to Wedbush, the prior rating for The GEO Group Inc (NYSE:GEO) was changed from Neutral to…
Berenberg Initiates Coverage On Ginkgo Bioworks Holdings with Buy Rating, Announces Price Target of $6
Berenberg analyst Gaurav Goparaju initiates coverage on Ginkgo Bioworks Holdings (NYSE:DNA) with a Buy rating and announces Price Target of $6.
Looking Into Ginkgo Bioworks Holdings’s Recent Short Interest
Ginkgo Bioworks Holdings's (NYSE:DNA) short percent of float has fallen 14.12% since its last report. The company recently reported that it has 134.22 million shares sold short, which is 15.87% of all regular shares that are available for trading.
BrightView Holdings, America’s Car-Mart And Some Other Big Stocks Moving Lower On Thursday
U.S. stocks traded lower, with the Nasdaq dropping more than 100 points on Thursday. Here are some big stocks recording losses in today’s session.
Target, Holley, Ferroglobe And Other Big Losers From Wednesday
U.S. stocks closed mostly lower on Wednesday, with the Nasdaq Composite dropping around 175 points. Here is the list of some big stocks recording losses in the previous session.
Ginkgo Bioworks Stock Is Down After Hours: What’s Happening?
Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading lower in Tuesday's after-hours session after the company announced a proposed public offering.
Ginkgo Bioworks Announces Proposed Public Offering $100M Of Class A Common Stock
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) ("Ginkgo"),which is building the leading platform for cell programing and biosecurity, today announced that it intends to offer and sell $100 million of its